Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 4.54% | 75.04 | 0.0% | $1242.25m | |
| NVAX | Novavax, Inc. | 5.42% | 109.97 | 102.0% | $942.55m | |
| VXRT | Vaxart, Inc. | 40.02% | 16.97 | 0.0% | $747.74m | |
| AMGN | Amgen, Inc. | 1.22% | 253.09 | 1.3% | $694.77m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 4.12% | 641.23 | 2.5% | $656.50m | |
| GILD | Gilead Sciences, Inc. | 0.67% | 77.19 | 1.0% | $630.00m | |
| BIIB | Biogen, Inc. | 1.72% | 281.27 | 1.6% | $603.02m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.16% | 293.83 | 1.9% | $475.24m | |
| ILMN | Illumina, Inc. | 1.93% | 376.25 | 3.5% | $302.26m | |
| BNTX | BioNTech SE | 7.84% | 83.88 | 0.0% | $222.50m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.63% | 126.43 | 4.3% | $213.99m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.44% | 108.57 | 1.9% | $207.78m | |
| SGEN | Seattle Genetics, Inc. | 2.88% | 173.43 | 6.1% | $191.51m | |
| SRNE | Sorrento Therapeutics, Inc. | 2.85% | 7.94 | 1.8% | $187.49m | |
| IMMU | Immunomedics, Inc. | 1.70% | 40.65 | 11.0% | $175.52m |
Company Profile
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.